admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office...

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support...

Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity

Psyched Wellness Hires Del Mahabadi as Digital Marketing Consultant to Drive...

Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts...

PharmaTher Announces Positive Research Results for LSD Microneedle Patch

Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences, Participants...

PT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative...

Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté...

MindMed Appoints Robert Barrow as Chief Executive Officer and Director

1...172173174...218 Page 173 of 218

Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could...

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin